RPHM Insider Trading

Insider Ownership Percentage: 15.40%
Insider Buying (Last 12 Months): $10,579.44
Insider Selling (Last 12 Months): $0.00

Reneo Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Reneo Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Reneo Pharmaceuticals Share Price & Price History

Current Price: $3.10
Price Change: Price Decrease of -0.04 (-1.27%)
As of 09/27/2022 01:00 AM ET

This chart shows the closing price history over time for RPHM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Reneo Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/31/2022Michael CruseCOOBuy3,212$3.21$10,310.526,197View SEC Filing Icon  
8/29/2022Michael CruseCOOBuy83$3.24$268.9230,783View SEC Filing Icon  
8/25/2021Gregory J. FlesherCEOBuy8,000$8.00$64,000.00View SEC Filing Icon  
8/25/2021Michael CruseVPBuy2,500$7.45$18,625.002,500View SEC Filing Icon  
8/25/2021Vineet R. JindalCFOBuy5,000$7.44$37,200.005,000View SEC Filing Icon  
7/14/2021Bali MuralidharDirectorBuy111,736$8.50$949,756.00View SEC Filing Icon  
6/23/2021Bali MuralidharDirectorBuy20,710$9.28$192,188.80View SEC Filing Icon  
6/21/2021Bali MuralidharDirectorBuy32,659$9.03$294,910.77View SEC Filing Icon  
6/8/2021Bali MuralidharDirectorBuy16,605$9.50$157,747.50View SEC Filing Icon  
6/3/2021Bali MuralidharDirectorBuy12,100$9.25$111,925.00View SEC Filing Icon  
5/26/2021Bali MuralidharDirectorBuy5,915$9.38$55,482.70View SEC Filing Icon  
4/13/2021Holdings A/S NovoMajor ShareholderBuy666,666$15.00$9,999,990.002,763,711View SEC Filing Icon  
4/13/2021Niall O'donnellDirectorBuy200,000$15.00$3,000,000.00View SEC Filing Icon  
4/9/2021Venture Fund Iii L RivervestMajor ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing Icon  
See Full Table
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE.

He lives financially free trading this One Stock Once per month...
Ticker Revealed.

SEC Filings (Institutional Ownership Changes) for Reneo Pharmaceuticals (NASDAQ:RPHM)

75.45% of Reneo Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RPHM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Reneo Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/16/2022Federated Hermes Inc.30,000$80K0.0%+76.5%0.123%Search for SEC Filing on Google Icon
8/15/2022State Street Corp16,400$43K0.0%-81.6%0.067%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC172,585$0.46M0.0%N/A0.705%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC59,686$0.16M0.0%N/A0.244%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC23,000$61K0.0%N/A0.094%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp11,907$31K0.0%-82.6%0.049%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG54,550$0.15M0.0%+5,012.5%0.223%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE40,878$0.12M0.0%+24.0%0.167%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp68,424$0.20M0.0%+7.7%0.280%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.360,881$1.06M0.0%-1.8%1.475%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC22,347$65K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/4/2022Tybourne Capital Management HK Ltd.700,000$2.06M0.1%-6.7%2.862%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd13,482$0.12M0.0%N/A0.055%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp63,547$0.54M0.0%+7.7%0.260%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd13,482$0.12M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP1,143,185$8.52M0.2%+1.3%4.684%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.450,000$3.35M0.0%-10.0%1.844%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.294,281$2.19M0.0%+1.5%1.206%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund4,210$31K0.0%-67.6%0.017%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP20,000$0.19M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System8,726$81K0.0%N/A0.036%Search for SEC Filing on Google Icon
8/16/2021RA Capital Management L.P.62,217$0.58M0.0%N/A0.255%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al13,406$0.13M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP56,823$0.53M0.2%N/A0.233%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.13,371$0.13M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/16/2021State Street Corp60,915$0.57M0.0%N/A0.250%Search for SEC Filing on Google Icon
8/16/2021Federated Hermes Inc.17,000$0.16M0.0%N/A0.070%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp68,447$0.64M0.0%N/A0.282%Search for SEC Filing on Google Icon
8/13/2021Franklin Resources Inc.500,000$4.67M0.0%N/A2.059%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC72,069$0.67M0.0%N/A0.297%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.366,210$3.42M0.0%N/A1.508%Search for SEC Filing on Google Icon
8/13/2021FMR LLC187,500$1.75M0.0%N/A0.772%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.7,794$73K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/11/2021RiverVest Venture Management LLC2,409,220$22.48M4.4%N/A9.920%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp14,837$0.14M0.0%N/A0.061%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.289,824$2.70M0.0%N/A1.193%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG3,745$35K0.0%N/A0.015%Search for SEC Filing on Google Icon
8/10/2021Nicholas Investment Partners LP226,189$2.11M0.1%N/A0.931%Search for SEC Filing on Google Icon
8/6/2021Aisling Capital Management LP886,075$8.27M1.3%N/A3.649%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund12,980$0.12M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/2/2021NEA Management Company LLC4,786,921$44.66M0.6%N/A19.711%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Reneo Pharmaceuticals logo
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More on Reneo Pharmaceuticals

Today's Range

Now: $3.10
Low: $2.85
High: $3.48

50 Day Range

MA: $3.38
Low: $2.35
High: $4.85

52 Week Range

Now: $3.10
Low: $1.92
High: $10.00

Volume

72,963 shs

Average Volume

29,849 shs

Market Capitalization

$75.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Who are the company insiders with the largest holdings of Reneo Pharmaceuticals?

Reneo Pharmaceuticals' top insider shareholders include:
  1. Holdings A/S Novo (Major Shareholder)
  2. Michael Cruse (COO)
  3. Vineet R Jindal (CFO)
  4. Michael Cruse (VP)
  5. Bali Muralidhar (Director)
  6. Gregory J Flesher (CEO)
  7. Niall O'donnell (Director)
  8. Venture Fund Iii L Rivervest (Major Shareholder)
Learn More about top insider investors at Reneo Pharmaceuticals.

Who are the major institutional investors of Reneo Pharmaceuticals?

Reneo Pharmaceuticals' top institutional investors include:
  1. Citadel Advisors LLC — 0.71%
  2. Millennium Management LLC — 0.24%
  3. UBS Group AG — 0.22%
  4. Federated Hermes Inc. — 0.12%
  5. Renaissance Technologies LLC — 0.09%
  6. State Street Corp — 0.07%
Learn More about top institutional investors of Reneo Pharmaceuticals stock.

Which major investors are selling Reneo Pharmaceuticals stock?

In the previous quarter, RPHM stock was sold by these institutional investors:
  1. State Street Corp
  2. Northern Trust Corp

Which major investors are buying Reneo Pharmaceuticals stock?

Within the last quarter, RPHM stock was acquired by institutional investors including:
  1. Citadel Advisors LLC
  2. Millennium Management LLC
  3. UBS Group AG
  4. Renaissance Technologies LLC
  5. Federated Hermes Inc.
In the last year, these company insiders have bought Reneo Pharmaceuticals stock:
  1. Holdings A/S Novo (Major Shareholder)
  2. Michael Cruse (COO)
  3. Vineet R Jindal (CFO)
  4. Michael Cruse (VP)
  5. Bali Muralidhar (Director)
  6. Gregory J Flesher (CEO)
  7. Niall O'donnell (Director)
  8. Venture Fund Iii L Rivervest (Major Shareholder)
Learn More investors buying Reneo Pharmaceuticals stock.
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast
He predicted the 2020 crash a month before it happened…He predicted this year’s collapse back in January…

And now, he’s issuing a brand-new warning – along with a unique solution.
Details here.